Charles W. Newton - 04 May 2022 Form 4 Insider Report for Coherus BioSciences, Inc. (CHRS)

Role
Director
Signature
/s/ McDavid Stilwell, as Attorney-in-Fact for Charles Newton
Issuer symbol
CHRS
Transactions as of
04 May 2022
Transactions value $
$0
Form type
4
Filing time
06 May 2022, 18:50:55 UTC
Previous filing
18 Mar 2022
Next filing
28 Feb 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CHRS Stock Option (Right to Buy) Award $0 +54K $0.00 54K 04 May 2022 Common Stock 54K $9.72 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The underlying shares subject to the option vest and become exercisable as to 1/36th of the total number of shares subject to the option in successive, equal monthly installments measured from May 4, 2022, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date.